Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbro Numan Hellquist

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ Open|November 28, 2024
Who has the responsibility to inform relatives at risk of hereditary cancer? A population-based survey in SwedenKalle Grill, Amicia Phillips, Barbro Numan Hellquist, et al.
Journal of Medical Screening|February 23, 2012
Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in SwedenBarbro Numan Hellquist, Stephen W Duffy, Lennarth Nyström, et al.
Cancer|September 23, 2014
Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first childBarbro Numan Hellquist, Kamila Czene, Anna Hjälm, et al.
Trials|December 17, 2023
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)Carolina Hawranek, Hans Ehrencrona, Anna Öfverholm, et al.
Plos One|August 7, 2020
Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: A data linkage study from the Risk North databaseOlle Sjöström, Anna M Dahlin, Gustav Silander, et al.
Journal of Neuro-Oncology|June 30, 2026
Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertaintiesWendy Yi-Ying Wu, Barbro Numan Hellquist, Beatrice Melin, et al.
Cancers|February 25, 2022
Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk-A Population-Based Survey in SwedenCarolina Hawranek, Johan Maxon, Andreas Andersson, et al.
Neuro-Oncology Practice|March 18, 2024
Antidepressants and survival in glioma-A registry-based retrospective cohort studySonja Edström, Barbro Numan Hellquist, Maria Sandström, et al.
Cancer Causes & Control : CCC|January 19, 2025
The impact of socioeconomic status on glioma survival: a retrospective analysisMaria Söderlund, Carl Almqvist, Olle Sjöström, et al.
Hereditary Cancer in Clinical Practice|September 18, 2020
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in SwedenAndreas Andersson, Carolina Hawranek, Anna Öfverholm, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ Open|November 28, 2024
Who has the responsibility to inform relatives at risk of hereditary cancer? A population-based survey in SwedenKalle Grill, Amicia Phillips, Barbro Numan Hellquist, et al.
Journal of Medical Screening|February 23, 2012
Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in SwedenBarbro Numan Hellquist, Stephen W Duffy, Lennarth Nyström, et al.
Cancer|September 23, 2014
Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first childBarbro Numan Hellquist, Kamila Czene, Anna Hjälm, et al.
Trials|December 17, 2023
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)Carolina Hawranek, Hans Ehrencrona, Anna Öfverholm, et al.
Plos One|August 7, 2020
Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: A data linkage study from the Risk North databaseOlle Sjöström, Anna M Dahlin, Gustav Silander, et al.
Journal of Neuro-Oncology|June 30, 2026
Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertaintiesWendy Yi-Ying Wu, Barbro Numan Hellquist, Beatrice Melin, et al.
Cancers|February 25, 2022
Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk-A Population-Based Survey in SwedenCarolina Hawranek, Johan Maxon, Andreas Andersson, et al.
Neuro-Oncology Practice|March 18, 2024
Antidepressants and survival in glioma-A registry-based retrospective cohort studySonja Edström, Barbro Numan Hellquist, Maria Sandström, et al.
Cancer Causes & Control : CCC|January 19, 2025
The impact of socioeconomic status on glioma survival: a retrospective analysisMaria Söderlund, Carl Almqvist, Olle Sjöström, et al.
Hereditary Cancer in Clinical Practice|September 18, 2020
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in SwedenAndreas Andersson, Carolina Hawranek, Anna Öfverholm, et al.
Pageof 2